Aerosol drug delivery to intubated neonates SIR,-We were pleased to read the two articles concerning aerosol drug delivery to intubated neonates by O'Callaghan et al ' and Grigg et al.2 
In particular, methods to determine the dosage available from the various devices should prove useful for investigators developing new means for aerosol delivery to intubated patients. We have previously described a device similar to the Aerochamber and not unlike the 'collapsible spacer' of O'Callaghan et al. We characterised its performance using beclomethasone dipropionate.3 As noted in both of the new reports,' 2 most of the drug released from the metered dose inhaler (MDI) does not reach the lung. We found just over 50% of the drug was actually aerosolised into the spacer.
With our device, the output from the tip of the endotracheal tube was 
Professor Milner and Dr Greenough comment:
We are grateful for Dr Wright's comments in response to our paper. We agree that there are considerable problems associated with the placing of the capsule, and that even when attached to the lower abdominal wall it is possible to achieve a situation in which the ventilator is then triggered by the baby's expiratory rather than inspiratory efforts. We are less optimistic that improvements in airway trigger design will overcome all problems as our experience has shown that in the first 24 hours of life, and in those of less than 28 weeks' gestation, respiratory efforts are often too erratic and insufficiently sustained for this technique.
Although we consider that the place of triggered ventilation is probably secure, we remain convinced that all new techniques introduced into neonatal intensive care must be subject to carefully designed prospective control trials to assess their effects on longterm outcome.
Catabolic effect of dexamethasone in the preterm baby SIR,-In the recent article by Brownlee et al their assessment of the catabolic effect of dexamethasone in the preterm infant promoted some active discussion.' One of the points of debate is whether the increase in blood urea observed was due solely to the effect of occult gastrointestinal haemorrhage that is seen and recognised in steroid treatment.2-4 The already falling creatinine concentrations would then be in keeping with these findings. 
